Re-examining antidepressant risk of self-injury in children and adolescents

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 2, 2015, Pages 215-217

  Olfson, Mark ^a   Gerhard, Tobias ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PRESCRIPTION DRUG; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; ATTRIBUTABLE RISK; AUTOMUTILATION; BORDERLINE STATE; CHILD; CHILD PSYCHIATRY; CHILD SAFETY; DEPRESSION; DISEASE ASSOCIATION; DRUG SAFETY; FAMILY HISTORY; HIGH RISK PATIENT; HOPELESSNESS; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MENTAL PATIENT; META ANALYSIS (TOPIC); PATIENT HARM; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SOCIAL PROBLEM; SUBSTANCE ABUSE; SUICIDAL IDEATION; SUICIDE ATTEMPT; THREAT; SELF-INJURIOUS BEHAVIOR; STATISTICS AND NUMERICAL DATA;

ANTIDEPRESSIVE AGENTS; HUMANS; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED;

EID: 84921634749     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3737     Document Type: Article

References (16)

1. Gibbons RD, Perraillon MC, Hur K, Conti RM, Valuck RJ, Brent DA. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidem Dr S, In Press.
2. Cougle JR, Keough ME, Riccardi CJ, Sachs-Ericsson N. Anxiety disorders and suicidality in the National Comorbidity Survey-Replication. J Psychiatr Research 2009; 43: 825-829.
3. Nock MK, Joiner TE, Jr, Gordon KH, Lloyd-Richardson E, Prinstein MJ. Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts. Psychiatry Res 2006; 144: 65-72.
4. Aseltine RH, Jr, Schilling EA, James A, Glanovsky JL, Jacobs D. Age variability in the association between heavy episodic drinking and adolescent suicide attempts: fi ndings from a large-scale, school-based screening program. J Am Acad Child Adolesc Psychiatry 2009; 48: 262-70.
5. Hawton K, Saunders K, O'Connor RC. Suicide: Self-harm and suicide in adolescents. Lancet 2012; 379: 2373-2382.
6. Cole SR, Hernan MA, Robins JM, Anastos K, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epdiemiol 2003; 158: 687-694.
7. Deisenhammer EA, Ing CM, Strauss R, Kemmler G, Hinterhuber H, Weiss EM. The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry 2009; 70: 19-24.
8. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63: 332-339.
9. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297(15): 1683-96.
10. March JS, Silva S, Petrycki S, Curry J, Wells K, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007; 64: 1132-1144.
11. Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 2009; 339: b2880.
12. Richardson LP, Ludman E, McCauley E, Lindenbaum J, Larison C, Zhou C, Clarke G, Brent D, Katon W. Colllaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA 2014; 312(8): 809-816.
13. Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry 2014; 71: 81-90.
14. Olfson M, He JP, Merikangas KR. Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement. J Am Acad Child Adolesc Psychiatry 2013; 52: 378-388.
15. Merikangas KR, He JP, Rapoport J, Vitiello B, Olfson M. Psychotropic medication use in a national sample of US adolescents by specific mental disorders. JAMA Pediatrics 2013; 167: 141-148.
16. King M, Essick C. The geography of antidepressant, antipsychotic, and stimulant utilization in the United States. Health Place 2013; 20: 32-28.